The future of healthcare belongs to those who can turn innovation into impact. Read more.
Discover how ICH E6(R3) is redefining clinical trials with a modern, flexible, and patient-centric approach
Small pharma companies rely on CROs for expertise, cost-effectiveness, flexibility, and strong communication in clinical trials.
Learn how the new EMA guideline on computerised systems is shaping the future of clinical trials. Discover the challenges of electronic systems and.
The ICH GCP E6 Working Group published the draft of the ICH GCP E6 R3 Guidance on May 19, 2023. Stakeholders can provide comments on the guideline.
The EU Commission released a recommendation paper on decentralized elements in clinical trials in late 2022. The document addresses the increasing...
Focus on the important updates of the publishes Guideline on Computerized Systems and Electronic Data for Clinical Trials.
-1.webp)
